PB2090: SYSTEMATIC LITERATURE REVIEW OF PROGNOSTIC FACTORS FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
Main Authors: | Shaji Kumar, Xavier Leleu, Katja Weisel, Rakesh Popat, Samantha Craigie, Leena Patel, Abril Oliva Ramirez, Wenzhen Ge, Qiufei MA, Christian Hampp, Sundar Jagannath |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000975152.94267.34 |
Similar Items
-
Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond
by: Klaus Podar, et al.
Published: (2021-10-01) -
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
by: Shaji Kumar, et al.
Published: (2022-06-01) -
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
by: Larysa Sanchez, et al.
Published: (2021-01-01) -
PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION
by: Cesar Rodriguez Valdes, et al.
Published: (2023-08-01) -
Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01)